On May 8, 2025, the Food and Drug Administration (FDA) announced the completion of its generative artificial intelligence (AI) pilot program ...

Tempus' FDA-approved xT CDx test is being used as an investigational assay in Verastem's global Phase 3 RAMP-301 clinical trial.

Anne Schmitz, University of Wisconsin-Stout and Daniel Freedman, University of Wisconsin-Stout (THE CONVERSATION) Three-dimensional printing is transforming medical care, letting the health care field ...

High-density design makes EdgeCore’s Mesa, Arizona data centers a near-term solution for hyperscale AI and cloud applications ...

Cortechs.ai has announced a strategic partnership with ALZ-NET aimed at improving the quality of care for Alzheimer's.

AstraZeneca PLC (NASDAQ:AZN), a pharmaceutical and biotech firm based in Cambridge, UK, reported positive results from its ...

Gaming for health! Maria Clara Mesa uses gamification & behavioral science to create digital health solutions. Learn how play ...

With lung cancer rates among non-smokers rising, especially young East Asian women, a new study released Monday is touting ...

Traditionally, HER2 status has been determined by immunohistochemistry (IHC) and in situ hybridization (ISH), distinguishing ...

If the initiative proceeds as planned, it will mark a pivotal shift in the regulatory landscape, introducing both efficiencies and novel ...

Me gene privacy question takes a turn in bankruptcy Why a big AI player wants a quarter-million bucks from 23andMe Why a big ...

The FDA and NIH recently announced plans to phase out animal testing requirements for some therapies. While organoid and AI ...